Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Treatment of diabetic neuropathy with gamma-linolenic acid. The gamma-Linolenic Acid Multicenter Trial Group.

Keen H, Payan J, Allawi J, Walker J, Jamal GA, Weir AI, Henderson LM, Bissessar EA, Watkins PJ, Sampson M, et al.

Diabetes Care. 1993 Jan;16(1):8-15.

PMID:
8380765
2.
3.

The use of gamma-linolenic acid in diabetic neuropathy.

Horrobin DF.

Agents Actions Suppl. 1992;37:120-44. Review.

PMID:
1321553
4.
5.

Sodium valproate in the management of painful neuropathy in type 2 diabetes - a randomized placebo controlled study.

Kochar DK, Jain N, Agarwal RP, Srivastava T, Agarwal P, Gupta S.

Acta Neurol Scand. 2002 Nov;106(5):248-52.

PMID:
12371916
6.

A lipoic acid-gamma linolenic acid conjugate is effective against multiple indices of experimental diabetic neuropathy.

Hounsom L, Horrobin DF, Tritschler H, Corder R, Tomlinson DR.

Diabetologia. 1998 Jul;41(7):839-43.

PMID:
9686927
7.

Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study.

Hotta N, Toyota T, Matsuoka K, Shigeta Y, Kikkawa R, Kaneko T, Takahashi A, Sugimura K, Koike Y, Ishii J, Sakamoto N; SNK-860 Diabetic Neuropathy Study Group..

Diabetes Care. 2001 Oct;24(10):1776-82. Erratum in: Diabetes Care 2002 Feb;25(2):413-4.

PMID:
11574441
9.

Withdrawal of the aldose reductase inhibitor tolrestat in patients with diabetic neuropathy: effect on nerve function. The Tolrestat Study Group.

Santiago JV, Snksen PH, Boulton AJ, Macleod A, Beg M, Bochenek W, Graepel GJ, Gonen B.

J Diabetes Complications. 1993 Jul-Sep;7(3):170-8.

PMID:
8343611
11.

Is ACE inhibition with lisinopril helpful in diabetic neuropathy?

Reja A, Tesfaye S, Harris ND, Ward JD.

Diabet Med. 1995 Apr;12(4):307-9.

PMID:
7600744
12.

Diabetic neuropathy in patients with "latent autoimmune diabetes of the adults" (LADA) compared with patients with type 1 and type 2 diabetes.

Baum P, Hermann W, Verlohren HJ, Wagner A, Lohmann T, Grahmann F.

J Neurol. 2003 Jun;250(6):682-7.

PMID:
12796829
13.

One-year treatment with the aldose reductase inhibitor, ponalrestat, in diabetic neuropathy.

Ziegler D, Mayer P, Rathmann W, Gries FA.

Diabetes Res Clin Pract. 1991 Oct;14(1):63-73.

PMID:
1748064
15.

Essential fatty acids in the management of impaired nerve function in diabetes.

Horrobin DF.

Diabetes. 1997 Sep;46 Suppl 2:S90-3. Review.

PMID:
9285506
16.

Sodium valproate for painful diabetic neuropathy: a randomized double-blind placebo-controlled study.

Kochar DK, Rawat N, Agrawal RP, Vyas A, Beniwal R, Kochar SK, Garg P.

QJM. 2004 Jan;97(1):33-8.

PMID:
14702509
17.
Items per page

Supplemental Content

Support Center